Staging Laparoscopy is Underutilized in the Management of Gastric Adenocarcinoma
Staging laparoscopy (SL) with peritoneal lavage is usually performed on a separate day from the planned resection and is recommended in patients with gastric adenocarcinoma as it can identify radiographically occult metastases and malignant cytology, thus altering prognosis and treatment. SL can be done on the same day as planned resection (SLSR) or with delayed resection (SLDR). The purpose of this study was to determine utilization of SL and factors associated with SLSR and SLDR, among patients diagnosed with gastric adenocarcinoma.
SEER-Medicare linked data were used to identify patients diagnosed with gastric adenocarcinoma from 2004 through 2013. SL were defined as a laparoscopy that occurred up to 3 months postdiagnosis. Multivariate logistic regression was used to identify factors associated with the utilization of SLSR and SLDR.
Of the 5610 patients with gastric adenocarcinoma who underwent a surgical procedure, 733 (13%) had a SL. Utilization of SL increased annually from 6.4% to 22.2% (p < 0.01). Receipt of SL was associated with patient demographics, tumor location, and treatment at a National Cancer Institute (NCI) Designated Cancer Center (CC). Of the 733 patients who underwent SL, 475 (65%) received further surgical procedures; 367 (77%) underwent SLSR, while 108 patients (23%) underwent SLDR. Compared with SLSR, SLDR was more common among patients who were younger, treated at an NCI-Designated CC and had proximal tumors.
SL for optimal preoperative staging remains underutilized in the management of gastric adenocarcinoma. Expanded use of laparoscopy as a distinct procedure could minimize unnecessary interventions.
Study conception and design: EMG, ZJB, LE, JMH, JLD; Acquisition of data: EMG, ZJB, LE, SG; Analysis and interpretation of data: EMG, ZJB, LE, SG, JMH, JLD; Drafting of manuscript: EMG, ZJB, LE, SG, JMH, JLD; Critical revisions: EMG, ZJB, LE, SG, LG, JMH, JLD.
The authors declare they have no conflicts of interest.
- 9.SEER. Available at: http://seer.cancer.gov/registries/terms.html.
- 10.National Cancer Institute. NCI-Designated Cancer Centers. Available at: https://www.cancer.gov/research/nci-role/cancer-centers. Accessed 15 Nov 2017.
- 12.NCCN. NCCN clinical practice guidelines in oncology, gastric cancer. 2019.Google Scholar
- 14.Washington KJA. 7th Edition of the AJCC Cancer Staging Manual: stomach. 2010;17(12):3077–9.Google Scholar